Evidence map›Paper›PMID 30564369›Full record

ArticleJournal of pharmaceutical policy and practice2018

To sell or not to sell; the differences between regulatory and community demands regarding access to antibiotics in rural Ghana.

Samuel Afari-Asiedu, John Kinsman, Ellen Boamah-Kaali, Martha Ali Abdulai, Margaret Gyapong, Osman Sankoh, Marlies Hulscher, Kwaku Poku Asante, Heiman Wertheim

Abstract read
In one paragraph

Article in Journal of pharmaceutical policy and practice, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Samuel Afari-Asiedu1Kintampo Health Research Centre, Ghana Health Service, P. O Box 200, Kintampo, Brong Ahafo Region, Ghana.ORCID 0000-0002-3355-411X
John Kinsman3Epidemiology and Global Health Unit, Umeå University, Umeå, Sweden.
Ellen Boamah-Kaali1Kintampo Health Research Centre, Ghana Health Service, P. O Box 200, Kintampo, Brong Ahafo Region, Ghana.
Martha Ali Abdulai4Kintampo Health Research Centre, P.O Box 200, Kintampo, Brong Ahafo Region, Ghana.
Margaret Gyapong5Centre for Health Policy and Implementation Research, University of Health and Allied Sciences, Ho, Ghana.
Osman SankohStatistics Sierra Leone, Freetown, Sierra Leone.
Marlies HulscherScientific Center for Quality of Healthcare, Radboud University Medical Center, Institute for Health Sciences, Radboud University, Nijmegen, Netherlands.
Kwaku Poku Asante1Kintampo Health Research Centre, Ghana Health Service, P. O Box 200, Kintampo, Brong Ahafo Region, Ghana.
Heiman WertheimRadboud University Medical Center, Institute for Health Sciences, Radboud University, Nijmegen, Netherlands.

Funding

Wellcome Trust
6 · The paper itself

Abstract

backgroundIn Ghana, there is extensive over-the-counter dispensing of antibiotics, resulting in high levels of inappropriate use, and an increase in antibiotic resistance. Regulations prevent Licenced Chemical Sellers (LCS, Over-the-Counter Medicine Sellers) from selling antibiotics other than Cotrimoxazole. In practice, however, these sellers sell a variety of antibiotics. This paper aims to provide insight into the differences between regulatory and community demands on the sale of antibiotics, and to explore how these differences in demand could be resolved to facilitate safe and appropriate use of antibiotics in rural Ghana.

methodsA total of 32 in-depth interviews were conducted in the Kintampo North and South Districts in Ghana; 16 among antibiotic suppliers, predominantly LCS, and 16 among community members. Six focus group discussions were also conducted among 40 community members. Data were coded using Nvivo 10 and thematically analyzed in line with study objectives. The results are presented as narratives with quotes to illustrate the findings.

resultsGenerally, antibiotic suppliers were aware that regulations prevent LCS from selling antibiotics except Cotrimoxazole. However, LCS sell all types of antibiotics because of community demand, economic motivations of LCS, and the poor implementation of regulations that are intended to prevent them from selling these medications. Factors that influence community demand for antibiotics include previous knowledge of effectiveness of some antibiotics, delays in seeking care at health facilities, financial constraints, and distance to health facilities. LCS suggested that they should be trained and allowed to sell some types of antibiotics instead of being prevented completely from selling. Community members also suggested that Community-based Health Planning and Services (CHPS) compounds should be equipped to dispense antibiotics.

conclusionThe sale of antibiotics by LCS at the community level is influenced by both structural and individual contextual factors. There is a need to educate community members on the appropriate access and use of antibiotics in rural Ghana. In addition, rather than enforcing rules that go against practice, it may be more effective to regulate the sale of antibiotics by LCS and train them to make their dispensing more appropriate. CHPS compound could also be equipped to dispense some antibiotics to improve appropriate antibiotic access at the community level.

Indexed as

Antibiotics accessGhanaLicensed chemical sellersPharmaceutical regulations

Identifiers

PMID30564369
PMCPMC6293650

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.